Four patients with glioblastoma multiforme were treated with high dose BCNU, 800 mg/m2, and autologous marrow transplantation. Two patients were treated in their first and 2 in their second remission. All patients are alive between 1 and 12 months from transplantation.
Get full access to this article
View all access options for this article.
References
1.
BloomH.J.G.: Combined modality therapy for intracranial tumors.Cancer, 35: 111–120, 1975.
2.
BroderL.E.E.RailD.P.: Chemotherapy of brain tumors.In: Progress in experimental tumor research.BingamW.G. (ed.), p. 373. Karger Basel, 1972.
GutinP.H.WilsonC.B.KumarA.R.W.BoldreyE.B.LevinV.PowellM.EnotK.J.: Phase II study of Procarbazine, CCNU and vincristine combination chemotherapy in the treatment of malignant brain tumors.Cancer, 35: 1398–1404, 1975.
5.
HochbergF.H.OarkerL.M.TakvorianT.ZervaH.CanellosG.: High dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.New Engl. J. Med., in press.
6.
MonfardiniS.: La terapia medica dei tumori del sistema nervoso centrale. II corso Agg.One. Med. Ambrosiana Milano, 1975, p. 301–315.
7.
SoleroC.L.MonfardiniS.BrambillaC.: Controlled study with BCNU-CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme.Cancer Clin. Trials, 2: 43–48, 1979.
8.
WalkerM.D.: Nitrosureas in central nervous system tumors.Cancer Chemother. Rep., 4: 21–26, 1973.
9.
WalkerM.D.GreenS.B.ByarD.P.AlexanderE.Jr., BatzdorfU.BrooksW.H.HuntW.E.Mc CartyC.S.MahaleyM.S.Jr., MealeyJ.Jr., OwensG.RansohoffJ.RobertsonJ.T.ShapiroW.R.SmithK.R.Jr., WilsonC.B.StrikeT.A.: Randomized comparisons of radiotherapy and nitrosureas for the treatment of malignant glioma after surgery.New Engl. J. Med., 303: 1323–1329, 1980.
